A claimant has had a radical prostatectomy and the surgery itself is not in dispute. What is in dispute is everything that followed: erections that never returned, a dry orgasm nobody warned him about, a shorter penis, and a partner who is now in the middle of it. Erectile dysfunction after prostatectomy is common, which is exactly why it is easy to under-prove and easy to over-claim. The useful questions are how much of the problem was expected, how much was avoidable, and what it will mean over the next 20 years.
In short
- Erectile outcomes after prostatectomy vary widely between studies, mostly because of how recovery is defined and who was studied.
- Loss of ejaculation is an expected result of the operation. Orgasm changes, urine leakage at climax and penile shortening are also well described.
- Population data show the average loss. They cannot show what this claimant lost, which depends on his baseline function, age and surgery.
- Good instructions ask about erections, ejaculation, orgasm, length, partner impact and treatment, and ask what the claimant was told before surgery.
What does the literature say about erectile dysfunction after prostatectomy?
Published recovery rates are wide.
One review of robotic surgery reported 12 month recovery rates from 54% to 90%, and 24 month rates from 63% to 94%.
That review is a good reminder that a single quoted figure should make you ask where it came from.
A meta-analysis found that recovery rates depend heavily on the definition of erectile dysfunction, how data were collected, the time point and the population.
The abstract page for that analysis sets out those variables.
Australian registry data are more useful for typical men. In the bi-national registry,
13,083 men reported outcomes at 12 months. The mean sexual function score was 29 out of 100, and 46% reported major bother.
See the registry study. The registry’s 2024 annual report found that only about a third of low-risk men who had surgery described their erections as fair to good a year later.
The longest randomised follow-up is the ProtecT trial.
At 7 years, 18% of the prostatectomy group reported erections sufficient for intercourse, compared with 30% on active monitoring and 27% after radiotherapy. All groups converged to low levels by year 12.
The trial summary has the detail. Two cautions apply.
The surgery was mostly open retropubic.
And
about a third of participants had erectile dysfunction before treatment.
That baseline figure is the one a defendant will reach for first.
The factors that predict outcome are consistent.
A systematic review identified age under 60, completeness of nerve-sparing and pre-operative sexual function.
That is summarised here. Registry data point the same way:
baseline sexual function, age, cancer risk category and intention to nerve-spare were key determinants.
See the international registry paper.
Ejaculation and orgasm: what is expected and what varies
Anejaculation is the one outcome that is not in doubt.
The prostate and seminal vesicles are removed and the vas deferens is disconnected, so ejaculation is expected to be absent.
The clinical management review makes this point. It also reports that
60% of men in one study did not know anejaculation was expected.
A claimant who says he was never told is describing something that happens often.
Other changes are variable.
Studies report orgasmic dysfunction in 27% to 93% of men after prostatectomy.
Climacturia, which is urine leakage at orgasm, has a similarly wide range.
Reported prevalence runs from 15.7% to 93%.
See this urology review. Ranges that wide tell you the studies counted different things.
When men are asked directly, the numbers rise. A Brazilian study of men with erectile dysfunction after surgery asked about orgasm and urinary leakage in a structured visit.
Climacturia was reported by 40 men (66.6%), and most of those described the losses as mild.
The authors concluded these problems are
often overlooked in preoperative counselling.
The same applies to claims. If nobody asks, nobody records it. I discuss this pattern in sexual dysfunction as an overlooked head of damage.
Penile length changes after prostatectomy
Shortening is real and usually partly recovers. In a long-term prospective study,
stretched length fell by an average of 1 cm at 3 months and was still 0.6 cm below baseline at 36 months.
The same study found a trend toward recovery after 24 months.
Length was fully re-established by 48 months, and preserved erectile function predicted recovery.
The journal abstract gives the conclusion.
A claimant’s report of loss can differ from measured loss. That is a clinical finding to document, and it should not be dismissed. It also means a report that records length without a time point since surgery is of limited use.
Does penile rehabilitation change the picture?
It matters for what treatment is reasonable and for prognosis. The evidence is weaker than many claimants and clinicians assume. An umbrella review concluded that
rehabilitation after prostatectomy remains a challenge with poor evidence.
It added that
PDE5 inhibitors improve function during treatment, but support for spontaneous recovery is limited.
That full text also describes
penile prosthesis as the most reliable definitive option for refractory cases.
An earlier systematic review found
no long-term data beyond 12 months
on the main outcomes. This has two uses. A defendant cannot easily argue that earlier treatment would have restored natural erections. A claimant cannot easily argue that a rehabilitation program would have. Treatment is better framed as assisted function, with a prosthesis considered if other options fail. Which option suits this man is a urology decision, informed by the sexual health assessment.
What the literature cannot do for a claim
Population data describe groups. They cannot tell you whether this claimant would have recovered without the alleged breach. Three limits come up repeatedly:
- Baseline. A man with pre-existing erectile dysfunction, diabetes or vascular disease starts from a different place. Baseline needs to be established from the claimant, the partner and the records.
- Surgical technique. Whether nerves were spared, and how well, is a question for the surgeon and a urology expert.
- Consent. Where a claim turns on what was disclosed, the sexual outcomes the claimant was told to expect need to be documented. A sexology expert can describe the usual outcomes and what a man in his position would typically understand. The legal question stays with the court.
Cancer treatment, mood, medication and age also affect sexual function. A careful report separates these where it can, and says so plainly where it cannot.
What to put in your instructions
These are the points I find most useful when instructed on a prostatectomy matter. The general principles are in how to brief a sexology expert.
- Date and type of surgery, and whether nerve-sparing was planned or achieved, from the operation report.
- Pre-operative sexual function, including any prior treatment for erectile problems.
- Consent documents and any notes of what was discussed about erections, ejaculation, orgasm and length.
- Treatments tried since surgery, with doses, response and reasons for stopping.
- Whether the partner can be interviewed, and any relationship history relevant to impact.
- Specific questions: current erectile status, ejaculation and orgasm, urinary leakage with sex, length, prognosis, future treatment, and what part of the dysfunction is attributable to the surgery or to other causes.
A sexual health assessment also puts numbers on the problem using validated instruments, which gives both sides something firmer than a general statement of impairment. Reading a sexology expert report explains how to use that structure in negotiation.
If you are considering instructions on a prostatectomy matter, you can see how I work on the medico-legal consultancy services page. A complimentary preliminary discussion is available to confirm scope before a formal referral, and you can reach me at info@arianasexology.com.
If it wasn’t assessed, it wasn’t claimed.
